NINDS Technology Transfer Office NINDS Technology Transfer Office NINDS Technology Transfer Office
Link to NINDS Home Site NINDS TTO Home Page Link to Neuroscience@NIH TTO Forms
About NINDS TTO
For Investigators
For Industry
Available Collaborations and Licenses
Useful Links

Material Transfer Agreement (MTA)
Confidential Disclosure Agreement (CDA)
Clinical Trial Agreement (CTA)
Cooperative Research and Development Agreement (CRADA and MCRADA)
Patenting
Public Disclosure
Licensing
Freedom of Information Act (FOIA)
Waiver of Patent Rights
Technology Transfer Issues When Research Staff Leaves NINDS

 

 
For Investigators 
 
Clinical Trial Agreement (CTA)
 

The CTA is required when a material is being brought into NINDS specifically with human research as an ultimate goal of the research. Preclinical work is often part of the CTA, but the end research goal of any CTA is human research. Many look upon the CTA as a “human research MTA” but it is in fact much more expansive and defining. Like the MTA, however, the CTA cannot promise intellectual property rights to the “partner” nor can it be utilized for materials that are commercially available.

The primary components of a CTA are:

  • Clarification of provider and recipients roles in the research
  • Development, design, and approval of the clinical trial protocol
  • IND ownership and FDA governed responsibilities
  • Data ownership and exchange
  • Publication rights and responsibilities
  • Termination and assurance of patient rights

 

 
Contact us at NINDS_TDC@mail.nih.gov
NINDS Home   |  NINDS TTO Home  | NeuroScience@NIH  |   Forms
DHHS   |  NIH  | FirstGov  |   Accessibility |   Privacy   | Site Index